FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023800668> ?p ?o ?g. }

• W2023800668 endingPage "14" @default.
• W2023800668 startingPage "7" @default.
• W2023800668 abstract "This study assessed the effects of intracerebroventricular administration of selective agonists and antagonists for tachykinin NK1 and NK2 receptors on performance of mice in the elevated plus-maze, an ethological model of anxiety. Mice were treated with either vehicle (5 microliters) or 1, 10, 100 or 500 pmol of substance P, neurokinin A, the selective NK1 receptor agonist substance P methyl ester, or the selective NK2 receptor agonist, [beta-Ala8]neurokinin A-(4-10). Other mice received similar doses of FK 888, i.e., N2-[(4R)-4-hydroxy-1-(1-methyl-1 H-indol-3-y)carbonyl-L-prolyl]-N-methyl-N-phenylmethyl-3-(2-naphthyl)-L- alaninamide, or SR 48968, i.e., (S)-N-methyl-(N-[4-acetylamine-4-phenylpiperidine)-2-(3, 4-dichlorophenyl)buthyl]benzamide, selective antagonists of tachykinin NK1 and NK2 receptors, respectively. Injections of substance P, neurokinin A, substance P methyl ester or [beta-Ala8]neurokinin A-(4-10) significantly reduced the frequency of open arm entries, and [beta-Ala8]neurokinin A-(4-10) also enhanced the percentage of entries into enclosed arms. Conversely, the NK1 antagonist FK 888 and the NK2 antagonist SR 48968 each increased the time spent in the open arms, and SR 48968 also increased the frequency of entries into the open arms. None of the tachykinin receptor agonists or antagonists modified motor performance and coordination on the rotarod apparatus or ambulation in an activity cage. Together, these results suggest that centrally administered NK1 and NK2 receptor agonists and antagonists can modulate anxiety, as evaluated in the elevated plus-maze test in mice. Stimulation of either tachykinin NK1 or NK2 receptors induces anxiogenic-like responses, whereas the reverse occurs following their blockade. The anxiolytic-like profiles of action of both tachykinin NK1 and NK2 receptor antagonists suggest that central tachykinin mechanisms are tonically involved in the modulation of anxiety." @default.
• W2023800668 created "2016-06-24" @default.
• W2023800668 creator A5009990459 @default.
• W2023800668 creator A5018561223 @default.
• W2023800668 creator A5031469258 @default.
• W2023800668 creator A5043712906 @default.
• W2023800668 creator A5067826212 @default.
• W2023800668 creator A5073378252 @default.
• W2023800668 date "1996-09-01" @default.
• W2023800668 modified "2023-10-01" @default.
• W2023800668 title "Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice" @default.
• W2023800668 cites W1484197568 @default.
• W2023800668 cites W1860985526 @default.
• W2023800668 cites W1974782548 @default.
• W2023800668 cites W1977517471 @default.
• W2023800668 cites W1978707089 @default.
• W2023800668 cites W1979390348 @default.
• W2023800668 cites W1983792284 @default.
• W2023800668 cites W1985068557 @default.
• W2023800668 cites W1986122115 @default.
• W2023800668 cites W1987674919 @default.
• W2023800668 cites W2003205209 @default.
• W2023800668 cites W2013990078 @default.
• W2023800668 cites W2014706144 @default.
• W2023800668 cites W2018021139 @default.
• W2023800668 cites W2020952504 @default.
• W2023800668 cites W2021655870 @default.
• W2023800668 cites W2028833035 @default.
• W2023800668 cites W2032058764 @default.
• W2023800668 cites W2039518601 @default.
• W2023800668 cites W2041561931 @default.
• W2023800668 cites W2043633068 @default.
• W2023800668 cites W2044699242 @default.
• W2023800668 cites W2046820639 @default.
• W2023800668 cites W2055790835 @default.
• W2023800668 cites W2056672572 @default.
• W2023800668 cites W2058895823 @default.
• W2023800668 cites W2075356407 @default.
• W2023800668 cites W2077442445 @default.
• W2023800668 cites W2082847226 @default.
• W2023800668 cites W2086175814 @default.
• W2023800668 cites W2091303128 @default.
• W2023800668 cites W2091554228 @default.
• W2023800668 cites W2094111864 @default.
• W2023800668 cites W2171952745 @default.
• W2023800668 doi "https://doi.org/10.1016/0014-2999(96)00390-1" @default.
• W2023800668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8884230" @default.
• W2023800668 hasPublicationYear "1996" @default.
• W2023800668 type Work @default.
• W2023800668 sameAs 2023800668 @default.
• W2023800668 citedByCount "154" @default.
• W2023800668 countsByYear W20238006682012 @default.
• W2023800668 countsByYear W20238006682013 @default.
• W2023800668 countsByYear W20238006682014 @default.
• W2023800668 countsByYear W20238006682016 @default.
• W2023800668 countsByYear W20238006682017 @default.
• W2023800668 countsByYear W20238006682018 @default.
• W2023800668 countsByYear W20238006682019 @default.
• W2023800668 countsByYear W20238006682021 @default.
• W2023800668 countsByYear W20238006682022 @default.
• W2023800668 crossrefType "journal-article" @default.
• W2023800668 hasAuthorship W2023800668A5009990459 @default.
• W2023800668 hasAuthorship W2023800668A5018561223 @default.
• W2023800668 hasAuthorship W2023800668A5031469258 @default.
• W2023800668 hasAuthorship W2023800668A5043712906 @default.
• W2023800668 hasAuthorship W2023800668A5067826212 @default.
• W2023800668 hasAuthorship W2023800668A5073378252 @default.
• W2023800668 hasConcept C118303440 @default.
• W2023800668 hasConcept C118552586 @default.
• W2023800668 hasConcept C126322002 @default.
• W2023800668 hasConcept C134018914 @default.
• W2023800668 hasConcept C137130169 @default.
• W2023800668 hasConcept C170493617 @default.
• W2023800668 hasConcept C173586616 @default.
• W2023800668 hasConcept C185592680 @default.
• W2023800668 hasConcept C202871150 @default.
• W2023800668 hasConcept C2776533618 @default.
• W2023800668 hasConcept C2776885963 @default.
• W2023800668 hasConcept C2777056410 @default.
• W2023800668 hasConcept C2778122271 @default.
• W2023800668 hasConcept C2778938600 @default.
• W2023800668 hasConcept C2780231548 @default.
• W2023800668 hasConcept C2781359426 @default.
• W2023800668 hasConcept C558461103 @default.
• W2023800668 hasConcept C55938493 @default.
• W2023800668 hasConcept C71240020 @default.
• W2023800668 hasConcept C71924100 @default.
• W2023800668 hasConcept C98274493 @default.
• W2023800668 hasConceptScore W2023800668C118303440 @default.
• W2023800668 hasConceptScore W2023800668C118552586 @default.
• W2023800668 hasConceptScore W2023800668C126322002 @default.
• W2023800668 hasConceptScore W2023800668C134018914 @default.
• W2023800668 hasConceptScore W2023800668C137130169 @default.
• W2023800668 hasConceptScore W2023800668C170493617 @default.
• W2023800668 hasConceptScore W2023800668C173586616 @default.
• W2023800668 hasConceptScore W2023800668C185592680 @default.
• W2023800668 hasConceptScore W2023800668C202871150 @default.
• W2023800668 hasConceptScore W2023800668C2776533618 @default.

• next